New drug aims to stop colorectal cancer recurrence in patients with hidden tumor DNA
NCT ID NCT07023289
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 2 trial tests whether the investigational drug telisotuzumab adizutecan can prevent colorectal cancer from coming back in patients who have no visible tumors but still have cancer DNA in their blood after surgery. About 140 adults will be randomly assigned to receive either the new drug or standard care. The study will track how long patients stay cancer-free and monitor side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
telisotuzumab adizutecan (ABBV-400)
What this could lead to
If successful, this could offer a new treatment option to prevent colorectal cancer from returning in patients with signs of residual disease after surgery.
What could go wrong
This is a phase 2 trial with only 140 participants, so results may not apply to everyone. The drug is investigational and may cause side effects or fail to improve outcomes compared to current care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aarhus Universitetshospital - Skejby /ID# 274498
RECRUITINGAarhus, Central Jutland, 8200, Denmark
-
Abramson Cancer Center at the University of Pennsylvania /ID# 275407
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Aichi Cancer Center /ID# 275479
RECRUITINGNagoya, Aichi-ken, 464-8681, Japan
-
Asan Medical Center /ID# 274454
RECRUITINGSeoul, Seoul Teugbyeolsi, 05505, South Korea
-
Azienda Ospedaliera Universitaria Federico II - Naples /ID# 273540
RECRUITINGNaples, Napoli, 80131, Italy
-
Azienda Ospedaliero Universitaria Careggi /ID# 273604
RECRUITINGFlorence, Firenze, 50134, Italy
-
China Medical University Hospital /ID# 274644
RECRUITINGTaichung, 40447, Taiwan
-
Clearview Cancer Institute - Huntsville - Cci Drive /ID# 278621
RECRUITINGHuntsville, Alabama, 35805, United States
-
Cliniques Universitaires UCL Saint-Luc /ID# 278669
RECRUITINGBrussels, Brussels Capital, 1200, Belgium
-
Duke University Medical Center /ID# 279457
RECRUITINGDurham, North Carolina, 27710, United States
-
Gifu University Hospital /ID# 274179
RECRUITINGGifu, Gifu, 501-1194, Japan
-
Hospital Universitario La Paz /ID# 273718
RECRUITINGMadrid, 28046, Spain
-
Hospital Universitario Virgen del Rocio /ID# 273720
RECRUITINGSeville, Sevilla, 41013, Spain
-
Hospital Universitario de Salamanca /ID# 273719
RECRUITINGSalamanca, 37007, Spain
-
IRCCS Istituto Clinico Humanitas /ID# 273566
RECRUITINGRozzano, Lombardy, 20089, Italy
-
Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 274586
RECRUITINGFairfax, Virginia, 22031, United States
-
Johns Hopkins Hospital /ID# 275645
RECRUITINGBaltimore, Maryland, 21287, United States
-
Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 273745
RECRUITINGKaohsiung City, 807, Taiwan
-
Kyushu University Hospital /ID# 273710
RECRUITINGFukuoka, Fukuoka, 812-8582, Japan
-
Massachusetts General Hospital /ID# 273608
RECRUITINGBoston, Massachusetts, 02114, United States
-
Mayo Clinic Hospital Jacksonville /ID# 274472
RECRUITINGJacksonville, Florida, 32224, United States
-
Mayo Clinic-Rochester /ID# 273508
RECRUITINGRochester, Minnesota, 55905, United States
-
Moffitt Cancer Center /ID# 274372
RECRUITINGTampa, Florida, 33612, United States
-
National Cancer Center Hospital East /ID# 273614
RECRUITINGKashiwa-shi, Chiba, 277-8577, Japan
-
National Hospital Organization Osaka National Hospital /ID# 274306
RECRUITINGOsaka, Osaka, 540-0006, Japan
-
National Taiwan University Hospital /ID# 273580
RECRUITINGTaipei, 100, Taiwan
-
Northwell Health Center for Advanced Medicine. /ID# 275331
RECRUITINGLake Success, New York, 11042, United States
-
Northwest Cancer Specialists /ID# 275151
RECRUITINGPortland, Oregon, 97227-1800, United States
-
Odense University Hospital /ID# 274970
RECRUITINGOdense C, Region Syddanmark, 5000, Denmark
-
Providence Medical Foundation - Fullerton /ID# 274207
RECRUITINGFullerton, California, 92835-3826, United States
-
SCRI Oncology Partners /ID# 274522
RECRUITINGNashville, Tennessee, 37203, United States
-
Samsung Medical Center /ID# 274452
RECRUITINGSeoul, Seoul Teugbyeolsi, 06351, South Korea
-
Scri Minnesota Oncology Hematology, P.A. /ID# 275149
RECRUITINGMinneapolis, Minnesota, 55404, United States
-
Seoul National University Hospital /ID# 274451
RECRUITINGSeoul, Seoul Teugbyeolsi, 03080, South Korea
-
Shizuoka Cancer Center /ID# 275480
RECRUITINGSunto-gun, Shizuoka, 411-8777, Japan
-
Texas Oncology - Central/South Texas /ID# 275154
RECRUITINGAustin, Texas, 78705, United States
-
Texas Oncology-Grapevine /ID# 275155
RECRUITINGGrapevine, Texas, 76051, United States
-
The Center For Cancer And Blood Disorders /ID# 278512
RECRUITINGFort Worth, Texas, 76104, United States
-
The University of Texas MD Anderson Cancer Center /ID# 273539
RECRUITINGHouston, Texas, 77030, United States
-
Tohoku University Hospital /ID# 275481
RECRUITINGSendai, Miyagi, 980-8574, Japan
-
USC Norris Comprehensive Cancer Center /ID# 274550
RECRUITINGLos Angeles, California, 90033, United States
-
Universitair Ziekenhuis Leuven /ID# 278668
RECRUITINGLeuven, Vlaams-Brabant, 3000, Belgium
-
University of Chicago Medical Center /ID# 274742
RECRUITINGChicago, Illinois, 60637, United States
-
University of Michigan Health System - Ann Arbor /ID# 273511
RECRUITINGAnn Arbor, Michigan, 48109, United States
-
Vejle Sygehus /ID# 274368
RECRUITINGVejle, Region Syddanmark, 7100, Denmark
-
Virginia Cancer Specialists - Fairfax /ID# 274339
RECRUITINGFairfax, Virginia, 22031, United States
-
Yokohama City University Medical Center /ID# 273657
RECRUITINGYokohama, Kanagawa, 232-0024, Japan